---
title: "A SPAC II ACQUISITION CORP C/WTS 15/10/2026 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285991959.md"
datetime: "2026-05-11T20:27:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285991959.md)
  - [en](https://longbridge.com/en/news/285991959.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285991959.md)
---

# A SPAC II ACQUISITION CORP C/WTS 15/10/2026 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 0

Revenue: As of FY2026 Q1, the actual value is USD 0.

EPS: As of FY2026 Q1, the actual value is USD -0.01.

EBIT: As of FY2026 Q1, the actual value is USD -79.68 K.

A SPAC II Acquisition Corp. operates as a single segment, focusing on activities related to its formation, initial public offering (IPO), and the search for a Business Combination target, and does not generate operating revenues .

#### Operational Metrics

-   **Net Loss**: For the three months ended March 31, 2026, the company reported a net loss of - $72,295, compared to a net loss of - $60,743 for the same period in 2025 .
-   **Loss from Operations**: The loss from operations was - $75,985 for the three months ended March 31, 2026, an improvement from - $108,778 for the three months ended March 31, 2025 .
-   **General and Administrative Expenses**: These expenses decreased to $75,985 for the three months ended March 31, 2026, from $108,778 in the prior year period .
-   **Interest Income**: Interest income significantly declined to $3,690 for the three months ended March 31, 2026, from $48,035 for the same period in 2025 .

#### Cash Flow

-   **Net Cash Used in Operating Activities**: The company used - $19,976 in cash from operating activities for the three months ended March 31, 2026, an improvement from - $128,383 used in the prior year period .
-   **Net Cash from Financing Activities**: For the three months ended March 31, 2026, net cash from financing activities was $120,000, primarily due to proceeds from a promissory note from a related party, compared to $0 in the prior year .
-   **Net Change in Cash**: The net change in cash was $100,024 for the three months ended March 31, 2026, a positive shift from a net change of - $128,383 for the three months ended March 31, 2025 .
-   **Cash, End of Period**: The cash balance increased to $100,159 as of March 31, 2026, from $12,598 as of March 31, 2025 .

#### Unique Metrics

-   **Investments Held in Trust Account**: These investments increased slightly to $530,997 as of March 31, 2026, from $527,330 as of December 31, 2025 .
-   **Working Capital Deficit**: The company reported a working capital deficit of - $701,315 as of March 31, 2026 .
-   **Promissory Note – Related Party**: The aggregate outstanding amount under promissory notes from a related party was $412,068 as of March 31, 2026, up from $292,068 as of December 31, 2025 .

#### Future Outlook and Strategy

A SPAC II Acquisition Corp.’s core business focus remains the completion of a Business Combination . The company has extended its deadline to consummate an initial Business Combination to August 5, 2027, and has approved undertaking a business combination with entities having principal business operations in China, including Hong Kong and Macau . Management has determined that the mandatory liquidation if a business combination does not occur, along with the need for additional financing, raises substantial doubt about the company’s ability to continue as a going concern .

### Related Stocks

- [ASCWF.US](https://longbridge.com/en/quote/ASCWF.US.md)

## Related News & Research

- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)
- [Equatorial Energia updates financial calendar for 2026 disclosures](https://longbridge.com/en/news/294368263.md)
- [Ciena's Q3 2026 Earnings: What to Expect](https://longbridge.com/en/news/293952665.md)
- [International Paper Q2 2026 Earnings Preview](https://longbridge.com/en/news/294266740.md)
- [Ama Corp posts Q2 2026 revenue release availability notice](https://longbridge.com/en/news/294317305.md)